Bevacizumab-Induced Alterations in Vascular Permeability and Drug Delivery: A Novel Approach to Augment Regional Chemotherapy for In-Transit Melanoma
Ryan S. Turley(Duke University), Douglas S. Tyler(University of North Carolina at Chapel Hill), Eugenia H. Cho(Duke University), Christina K. Augustine(Duke University), Yoshihiro Tokuhisa(Duke University), Georgia M. Beasley(Duke Medical Center), James C. Padussis(University of Nebraska Medical Center), Hiroaki Toshimitsu(Duke University), Andrew N. Fontanella(Duke University), Mark W. Dewhirst(Duke Medical Center), Gabi Hanna(University of North Carolina at Chapel Hill)
Cited by 57
Related Papers
Tumor Vascular Permeability, Accumulation, and Penetration of Macromolecular Drug Carriers
|JNCI Journal of the National Cancer Institute|2006|923
NCCN Task Force Report: Management of Patients with Gastrointestinal Stromal Tumor (GIST)—Update of the NCCN Clinical Practice Guidelines
|Journal of the National Comprehensive Cancer Network|2007|636
Overcoming Limitations in Nanoparticle Drug Delivery: Triggered, Intravascular Release to Improve Drug Penetration into Tumors
|Cancer Research|2012|458
Drug targeting using thermally responsive polymers and local hyperthermia
|Journal of Controlled Release|2001|410
The landscape of the mesenchymal signature in brain tumours
|Brain|2019|389